FDA Finalizes Guidance to Expand Clinical Trial Eligibility for Cancer Patients

The U.S. Food and Drug Administration (FDA) has finalized three guidance documents aimed at making oncology drug clinical trials more accessible. These documents encourage sponsors to re-evaluate eligibility criteria, potentially broadening patient participation in cancer research.